全文获取类型
收费全文 | 1356篇 |
免费 | 129篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 102篇 |
妇产科学 | 19篇 |
基础医学 | 170篇 |
口腔科学 | 57篇 |
临床医学 | 167篇 |
内科学 | 292篇 |
皮肤病学 | 16篇 |
神经病学 | 36篇 |
特种医学 | 270篇 |
外科学 | 119篇 |
综合类 | 26篇 |
预防医学 | 68篇 |
眼科学 | 56篇 |
药学 | 54篇 |
肿瘤学 | 55篇 |
出版年
2021年 | 11篇 |
2020年 | 10篇 |
2019年 | 13篇 |
2018年 | 25篇 |
2017年 | 15篇 |
2016年 | 12篇 |
2015年 | 18篇 |
2014年 | 27篇 |
2013年 | 25篇 |
2012年 | 31篇 |
2011年 | 36篇 |
2010年 | 42篇 |
2009年 | 33篇 |
2008年 | 24篇 |
2007年 | 46篇 |
2006年 | 30篇 |
2005年 | 23篇 |
2004年 | 21篇 |
2003年 | 29篇 |
2002年 | 25篇 |
2001年 | 26篇 |
2000年 | 28篇 |
1999年 | 25篇 |
1998年 | 70篇 |
1997年 | 81篇 |
1996年 | 87篇 |
1995年 | 58篇 |
1994年 | 43篇 |
1993年 | 56篇 |
1992年 | 38篇 |
1991年 | 26篇 |
1990年 | 33篇 |
1989年 | 52篇 |
1988年 | 50篇 |
1987年 | 40篇 |
1986年 | 46篇 |
1985年 | 58篇 |
1984年 | 20篇 |
1983年 | 21篇 |
1982年 | 14篇 |
1981年 | 13篇 |
1980年 | 15篇 |
1979年 | 13篇 |
1978年 | 10篇 |
1977年 | 16篇 |
1976年 | 11篇 |
1975年 | 10篇 |
1974年 | 10篇 |
1971年 | 9篇 |
1969年 | 7篇 |
排序方式: 共有1514条查询结果,搜索用时 15 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
4.
Haemophilus influenzae vaccine containing polyribosyl ribitol phosphate (PRP) or PRP covalently linked to diphtheria toxoid (PRP-D) was given to 94 healthy infants 17 to 22 months of age at the same time, but not at the same site, as a diphtheria-tetanus-pertussis booster. Systemic reactions were similar in the two vaccine groups and resembled those expected with the diphtheria-tetanus-pertussis injection alone. Six (13%) and seven (14%) of the PRP and PRP-D recipients, respectively, had minor local reactions to the Haemophilus vaccine. Among the 77 children who were not already naturally immune (ie, anti-PRP antibody concentration of less than or equal to 0.15 micrograms of protein per milliliter) before vaccination, PRP-D was significantly more effective than PRP in inducing protective levels of antibody. Only 15 (43%) of the 35 nonimmune PRP recipients achieved a concentration of greater than or equal to 0.15 microgram/mL and only seven (20%) reached a concentration greater than or equal to 1.0 micrograms/mL following vaccination. In contrast, 34 (81%) of the 42 nonimmune recipients of PRP-D had a concentration of greater than or equal to 0.15 microgram/mL following vaccine and 32 (62%) had a concentration of greater than or equal to 1.0 micrograms/mL (P less than or equal to .001). These results suggest that more than one-half of nonimmune 18-month-old infants will not respond to PRP with protective levels of antibody. In light of the current data, recommendation for revaccination at 24 months of age for those immunized at any younger age is appropriate. 相似文献
5.
6.
7.
8.
9.
Ten thrombocytopenic patients (platelets < 10–24 × 10(9)/L) who were refractory to platelet transfusion were investigated for their responsiveness to staphylococcal protein A column therapy. Nine patients had previously been treated with steroids, intravenous immune globulin, and/or other forms of immunosuppressive therapy without improvement in their transfusion response. All patients were receiving multiple platelet transfusions without achieving 1-hour corrected count increments (CCIs) > or = 7500. Eight patients had antibodies that reacted with platelets and were directed against HLA class I antigens, ABO antigens, and/or platelet-specific alloantigens. Plasma (500-2000 mL) from each patient was passed over a protein A silica gel column and then returned to the patient. Patients received from 1 to 14 treatments. A positive response to protein A therapy was defined as at least a doubling of the pretreatment platelet count and/or two successive 10- to 120-minute posttransfusion CCIs > or = 7500. Following plasma treatments, 6 of 10 patients responded with daily platelet counts that averaged 48 +/− 11 × 10(9) per L as compared with counts of 16 +/− 7 × 10(9) per L (p < 0.0005) before treatment. Posttransfusion CCI values determined in four of these patients averaged 2480 +/− 810 and 10,010 +/− 3540 (p < 0.005) before and after treatment, respectively. In contrast, among the four unresponsive patients, platelet counts averaged 10 +/− 9 and 13 +/− 10 × 10(9) per L (p = NS), respectively, while posttransfusion CCIs were 700 +/− 1410 and 1520 +/− 2460 (p = NS), respectively.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
10.
目的 探索LDH实验检测细胞活力的可行性。方法 原代培养骨髓细胞和软骨细胞,用LDH实验测定上述两组细胞的活力,并与镜下活体观察到细胞的生长状况相比较。与目前比较成熟的测定细胞活力的MTS实验的测得的值相比较。结果 LDH实验对上述两组细胞的活力的测定结果与镜下活体观察到的结果相符合。与MTS实验的测得的结果经统计学处理无显著差异。结论 LDH实验可用于细胞活力的直接测定,而对活细胞的生存、繁殖无影响。 相似文献